CROSSMEDIKA SA
GenericsCROSSMEDIKA SA is a generic drug manufacturer focused on Infectious Disease, Respiratory, Dermatology.
CROSSMEDIKA SA's Key Drugs
CROSSMEDIKA SA's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
CROSSMEDIKA SA's Recent FDA Approvals
New NDA/BLA approvals for CROSSMEDIKA SA over the last two years — novel drugs only, excluding generics and label supplements.
CROSSMEDIKA SA's Therapeutic Areas
CROSSMEDIKA SA's approved drugs and pipeline span 4 therapeutic areas, led by Infectious Disease and Respiratory. Weighted by commercial stage — approved drugs count most, then late-stage trials.
CROSSMEDIKA SA's Top Competitors
CROSSMEDIKA SA's closest competitors by therapeutic-area and drug-target overlap include Merck, APOTHECON, and Baxter. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
CROSSMEDIKA SA Pipeline Snapshot
Active clinical trials for CROSSMEDIKA SA across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Infectious Disease pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2016-01-14
- Latest
- 2025-06-24
- Applications
- 5